Bioptigen, a Durham, NC company, has developed advanced technology, through patent and licensing agreements with Duke University, in the field of Optical Coherence Tomography (OCT). OCT enables a non-invasive, real-time two- and three-dimensional imaging of living subjects with resolution up to 100-times finer than 4D ultrasound techniques.

Fatal error: Call to undefined function get_panel_name() in /home/pan1/public_html/wp-content/themes/PiedmontAngelNetwork/single.php on line 56